thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33729778-2A8CC969-B823-4824-8DF1-7035228C8231
Q33729778-2A8CC969-B823-4824-8DF1-7035228C8231
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33729778-2A8CC969-B823-4824-8DF1-7035228C8231
Population Pharmacokinetics of Selumetinib and Its Metabolite N-desmethyl-selumetinib in Adult Patients With Advanced Solid Tumors and Children With Low-Grade Gliomas.
P2860
Q33729778-2A8CC969-B823-4824-8DF1-7035228C8231
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33729778-2A8CC969-B823-4824-8DF1-7035228C8231
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
199ae0045980688d9eb3d470b00594d5730b5e9c
P2860
A phase I, open-label, randomized crossover study to assess the effect of dosing of the MEK 1/2 inhibitor Selumetinib (AZD6244; ARRY-142866) in the presence and absence of food in patients with advanced solid tumors